PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma - Publication - Bridge of Knowledge

Your account

login

Search

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Abstract

Citations

  • 9 0 3

    CrossRef

  • 0

    Web of Science

  • 9 2 5

    Scopus

Authors (22)

  • Photo of Ajay Gopal

    Ajay Gopal

  • Photo of Brad Kahl

    Brad Kahl

  • Photo of Sven de

    Sven de

  • Photo of Nina Wagner-Johnston

    Nina Wagner-Johnston

  • Photo of Stephen Schuster

    Stephen Schuster

  • Photo of MD, PhD, Prof Wojciech Jurczak

    Wojciech Jurczak MD, PhD, Prof

  • Photo of Ian Flinn

    Ian Flinn

  • Photo of Christopher Flowers

    Christopher Flowers

  • Photo of Peter Martin

    Peter Martin

  • Photo of Andreas Viardot

    Andreas Viardot

  • Photo of Kristie Blum

    Kristie Blum

  • Photo of Andre Goy

    Andre Goy

  • Photo of Andrew Davies

    Andrew Davies

  • Photo of Pier Zinzani

    Pier Zinzani

  • Photo of Martin Dreyling

    Martin Dreyling

  • Photo of Dave Johnson

    Dave Johnson

  • Photo of Langdon Miller

    Langdon Miller

  • Photo of Leanne Holes

    Leanne Holes

  • Photo of Daniel Li

    Daniel Li

  • Photo of Roger Dansey

    Roger Dansey

  • Photo of Wayne Godfrey

    Wayne Godfrey

  • Photo of Gilles Salles

    Gilles Salles

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
New England Journal of Medicine no. 370, edition 11, pages 1008 - 1018,
ISSN: 0028-4793
ISSN:
0028-4793
Publication year:
2014
DOI:
Digital Object Identifier (open in new tab) 10.1056/nejmoa1314583
Verified by:
No verification

seen 127 times

Meta Tags